Cited by

• Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study.

  Paioni P, Aebi-Popp K, Martinez de Tejada B, Rudin C, Bernasconi E, Braun DL, Kouyos R, Wagner N, Crisinel PA, Güsewell S, Darling KEA, Duppenthaler A, Baumann M, Polli C, Fischer T, Kahlert CR; Swiss HIV Cohort Study (SHCS) and the Swiss Mother and Child HIV Cohort Study (MoCHiV). Paioni P, et al. Lancet Reg Health Eur. 2023 Jun 1;31:100656. doi: 10.1016/j.lanepe.2023.100656. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37303945 Free PMC article.
• Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland.

  Tookey PA, Thorne C, van Wyk J, Norton M. Tookey PA, et al. BMC Infect Dis. 2016 Feb 4;16:65. doi: 10.1186/s12879-016-1400-y. BMC Infect Dis. 2016. PMID: 26847625 Free PMC article.
• Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis.

  Goetghebuer T, Haelterman E, Marvillet I, Barlow P, Hainaut M, Salameh A, Ciardelli R, Gerard M, Levy J. Goetghebuer T, et al. Eur J Pediatr. 2009 Jan;168(1):79-85. doi: 10.1007/s00431-008-0717-y. Epub 2008 Apr 5. Eur J Pediatr. 2009. PMID: 18392638
• Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.

  Yang S, Xu M, Lee EM, Gorshkov K, Shiryaev SA, He S, Sun W, Cheng YS, Hu X, Tharappel AM, Lu B, Pinto A, Farhy C, Huang CT, Zhang Z, Zhu W, Wu Y, Zhou Y, Song G, Zhu H, Shamim K, Martínez-Romero C, García-Sastre A, Preston RA, Jayaweera DT, Huang R, Huang W, Xia M, Simeonov A, Ming G, Qiu X, Terskikh AV, Tang H, Song H, Zheng W. Yang S, et al. Cell Discov. 2018 Jun 5;4:31. doi: 10.1038/s41421-018-0034-1. eCollection 2018. Cell Discov. 2018. PMID: 29872540 Free PMC article.
• Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen.

  Fox Z, Phillips A, Cohen C, Neuhaus J, Baxter J, Emery S, Hirschel B, Hullsiek KH, Stephan C, Lundgren J; SMART Study Group. Fox Z, et al. AIDS. 2008 Nov 12;22(17):2279-89. doi: 10.1097/QAD.0b013e328311d16f. AIDS. 2008. PMID: 18981767 Free PMC article. Clinical Trial.